KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dynavax Technologies (DVAX) EBT: 2009-2024

Historic EBT for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $30.9 million.

  • Dynavax Technologies' EBT rose 43.40% to $28.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$40.6 million, marking a year-over-year decrease of 267.65%. This contributed to the annual value of $30.9 million for FY2024, which is 806.55% up from last year.
  • Per Dynavax Technologies' latest filing, its EBT stood at $30.9 million for FY2024, which was up 806.55% from -$4.4 million recorded in FY2023.
  • In the past 5 years, Dynavax Technologies' EBT ranged from a high of $294.3 million in FY2022 and a low of -$75.2 million during FY2020.
  • Moreover, its 3-year median value for EBT was $30.9 million (2024), whereas its average is $106.9 million.
  • Per our database at Business Quant, Dynavax Technologies' EBT plummeted by 101.48% in 2023 and then spiked by 806.55% in 2024.
  • Over the past 5 years, Dynavax Technologies' EBT (Yearly) stood at -$75.2 million in 2020, then spiked by 203.03% to $77.5 million in 2021, then soared by 279.64% to $294.3 million in 2022, then tumbled by 101.48% to -$4.4 million in 2023, then spiked by 806.55% to $30.9 million in 2024.